CVS Caremark Reverses Zepbound Coverage After Backlash
3 stories
May 28
- CVS expands access to blockbuster weight-loss drugs in surprise reversal
The Independent · May 28
- STAT+: Pharmalittle: We’re reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more
statnews.com · May 28
- CVS Caremark will cover Lilly’s weight loss drug Zepbound again after patient backlash
NBC News · May 28